Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

News Feature in 2021

Filter By:

Article Type
Year
  • From a first-in-class KRAS approval to the latest agonist antibody failures, 2021 was another busy year for cancer drug developers.

    • Asher Mullard
    News Feature
  • Despite widespread vaccination, patients with cancer still face a slew of pandemic-related challenges.

    • Elie Dolgin
    News Feature

Search

Quick links